Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 18

1.

Medication safety curriculum: enhancing skills and changing behaviors.

Karpa KD, Hom LL, Huffman P, Lehman EB, Chinchilli VM, Haidet P, Leong SL.

BMC Med Educ. 2015 Dec 29;15(1):234. doi: 10.1186/s12909-015-0521-0.

2.

Adverse Effects of Common Drugs: Dietary Supplements.

Felix TM, Karpa KD, Lewis PR.

FP Essent. 2015 Sep;436:31-40. Review.

PMID:
26375996
3.

Adverse Effects of Common Drugs: Adults.

Lewis PR, Karpa KD, Felix TM.

FP Essent. 2015 Sep;436:23-30. Review.

PMID:
26375995
4.

Adverse Effects of Common Drugs: Children and Adolescents.

Karpa KD, Felix TM, Lewis PR.

FP Essent. 2015 Sep;436:17-22. Review.

PMID:
26375994
5.

Adverse Effects of Common Drugs: General Concepts.

Karpa KD, Lewis PR, Felix TM.

FP Essent. 2015 Sep;436:11-6. Review.

PMID:
26375993
6.

Creating a virtual pharmacology curriculum in a problem-based learning environment: one medical school's experience.

Karpa KD, Vrana KE.

Acad Med. 2013 Feb;88(2):198-205. doi: 10.1097/ACM.0b013e31827c083d.

PMID:
23269297
7.

Bacillus coagulans GBI-30, 6086 limits the recurrence of Clostridium difficile-Induced colitis following vancomycin withdrawal in mice.

Fitzpatrick LR, Small JS, Greene WH, Karpa KD, Farmer S, Keller D.

Gut Pathog. 2012 Oct 22;4(1):13. doi: 10.1186/1757-4749-4-13.

8.

Examining utilization of a natural medicine Web-based tool among non-primary care physicians, academic faculty, and nurses at one institution.

Karpa KD, Boehmer S.

Ann Pharmacother. 2012 Apr;46(4):513-20. doi: 10.1345/aph.1Q710. Epub 2012 Mar 27.

PMID:
22454447
9.

Bacillus Coagulans GBI-30 (BC30) improves indices of Clostridium difficile-Induced colitis in mice.

Fitzpatrick LR, Small JS, Greene WH, Karpa KD, Keller D.

Gut Pathog. 2011 Oct 20;3(1):16. doi: 10.1186/1757-4749-3-16.

10.

Clinical utility of probiotics in inflammatory bowel disease.

Cain AM, Karpa KD.

Altern Ther Health Med. 2011 Jan-Feb;17(1):72-9. Review.

PMID:
21614946
11.

Human patient simulation in pharmacology graduate education: bridging the bench-to-bedside gap.

Murray WB, Wood J, Schwab M, Fritz M, Karpa KD.

Mol Interv. 2010 Jun;10(3):127-32. doi: 10.1124/mi.10.3.2. No abstract available.

PMID:
20539030
12.

Lactobacillus and bifidobacteria combinations: a strategy to reduce hospital-acquired Clostridium difficile diarrhea incidence and mortality.

Graul T, Cain AM, Karpa KD.

Med Hypotheses. 2009 Aug;73(2):194-8. doi: 10.1016/j.mehy.2009.02.026. Epub 2009 Apr 8.

PMID:
19359104
13.

An evidence-based systematic review of passion flower (Passiflora incarnata L.) by the Natural Standard Research Collaboration.

Ulbricht C, Basch E, Boon H, Karpa KD, Gianutsos G, Nummy K, Seamon E, Smith M, Sollars D, Tanguay-Colucci S, Varghese M, Weissner W, Woods J.

J Diet Suppl. 2008;5(3):310-40. doi: 10.1080/19390210802414360. Review. No abstract available.

PMID:
22432466
14.

Probiotics for Clostridium difficile diarrhea: putting it into perspective.

Karpa KD.

Ann Pharmacother. 2007 Jul;41(7):1284-7. Epub 2007 Jun 26.

PMID:
17595302
15.

Pharmacist critique was ill-informed.

Karpa KD.

Ann Pharmacother. 2006 Jul-Aug;40(7-8):1441-4. Epub 2006 Jun 27.

PMID:
16804096
16.

Duloxetine pharmacology: profile of a dual monoamine modulator.

Karpa KD, Cavanaugh JE, Lakoski JM.

CNS Drug Rev. 2002 Winter;8(4):361-76. Review.

18.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk